Supernus (NASDAQ: SUPN) CFO receives performance share unit grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
SUPERNUS PHARMACEUTICALS, INC. reported that Senior Vice-President & CFO Timothy C. Dec acquired performance share units. On the reported transaction date, 3,000 performance share units were credited to his direct holdings at no exercise price. According to a footnote, these units were originally awarded on February 22, 2024, with a portion vesting upon achievement of individual performance objectives established on June 24, 2024.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
DEC TIMOTHY C
Role
Senior Vice-President & CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Share Unit | 3,000 | $0.00 | -- |
| Grant/Award | Performance Share Unit | 3,000 | $0.00 | -- |
Holdings After Transaction:
Performance Share Unit — 3,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did SUPN report for Timothy C. Dec?
SUPN reported that Senior Vice-President & CFO Timothy C. Dec acquired 3,000 performance share units. These derivative securities were credited at a price of $0.00 per unit and are held directly in his name as reflected after the reported transaction.
What type of security did the SUPN Form 4 transaction involve?
The Form 4 transaction for SUPN involved Performance Share Units, a type of derivative security. These units were granted at no cash cost and are linked to performance criteria rather than open-market share purchases or sales by the executive.
What performance conditions applied to SUPN CFO Timothy C. Dec’s units?
The award included individual performance objectives that had to be achieved within a defined performance period. These objectives were established on June 24, 2024, and a portion of the performance share units vested once those objectives were met, leading to the reported acquisition.
Does the SUPN Form 4 show a market purchase or sale by the CFO?
No, the Form 4 shows an acquisition coded as a grant or award, not a market trade. The 3,000 performance share units were credited at a price of $0.00 per unit, reflecting equity compensation tied to performance rather than a buy or sell in the open market.